New plasma and gas combo may fight deadly heart surgery infections
NCT ID NCT04617353
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a combined treatment using air-plasma flow and nitric oxide gas to prevent and treat wound infections after heart surgery. It included 80 patients with mediastinitis, a serious chest infection. The goal was to see if this approach could reduce infection, improve wound healing, and lower death rates.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
air-plasma flow and nitric oxide therapy
What this could lead to
If successful, this could offer a new way to prevent and treat serious wound infections after heart surgery, potentially reducing complications and deaths.
What could go wrong
This is a small, completed study with 80 participants, so results may not apply to all patients. The treatment is a procedure, not a drug, and its effectiveness compared to standard care is uncertain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MEDIASTINITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
TomskNRMC
Tomsk, Tomskay Oblast, 634012, Russia